More about

Aspirin

News
December 22, 2020
3 min read
Save

Low-dose aspirin led to low risk of VTE after shoulder arthroplasty

Low-dose aspirin led to low risk of VTE after shoulder arthroplasty

Use of low-dose aspirin yielded a low risk of venous thromboembolism and medication-associated complications after primary shoulder arthroplasty, according to results presented at the American Shoulder and Elbow Surgeons Annual Meeting.

News
November 17, 2020
2 min read
Save

Aspirin reduces risk for HCC in chronic hepatitis B

Aspirin reduces risk for HCC in chronic hepatitis B

For patients with chronic hepatitis B, aspirin therapy correlated with a reduced risk for hepatocellular carcinoma, according to a presenter at The Liver Meeting Digital Experience.

News
November 17, 2020
2 min read
Save

Ticagrelor-aspirin treatment effect in THALES strongest in ipsilateral stenosis

Ticagrelor-aspirin treatment effect in THALES strongest in ipsilateral stenosis

In new data from the THALES trial of patients with prior stroke, the benefit of ticagrelor plus aspirin for secondary stroke prevention was greatest in those with ipsilateral atherosclerotic stenosis.

News
November 16, 2020
3 min read
Save

Aspirin monotherapy after 1-month DAPT safe, effective after PCI with polymer-free stent

Aspirin monotherapy after 1-month DAPT safe, effective after PCI with polymer-free stent

One month of dual antiplatelet therapy followed by aspirin monotherapy after PCI with a polymer-free drug-coated stent was noninferior to 6 to 12 months of DAPT after PCI with a contemporary drug-eluting stent, researchers reported.

News
November 13, 2020
4 min read
Save

Daily polypill plus aspirin lowers risk for CVD, death

Daily polypill plus aspirin lowers risk for CVD, death

Adults at intermediate CV risk assigned a polypill plus aspirin were 31% less likely to experience a CV event or death compared with those assigned double placebo over a nearly 5-year period, according to new data from the TIPS-3 trial.

News
November 06, 2020
2 min read
Save

Ticagrelor gains FDA approval for secondary stroke prevention

Ticagrelor gains FDA approval for secondary stroke prevention

AstraZeneca announced the FDA approved its P2Y12 inhibitor ticagrelor for the reduction of stroke risk among patients with acute ischemic stroke or high-risk transient ischemic attack.

News
October 20, 2020
1 min read
Save

POPular CABG

POPular CABG

Saphenous vein graft occlusion, graft failure and bleeding with aspirin plus ticagrelor (Brilinta, AstraZeneca) after CABG compared with aspirin alone.

News
October 20, 2020
1 min read
Save

HOST-REDUCE-POLYTECH-ACS

HOST-REDUCE-POLYTECH-ACS

Net adverse clinical events in patients who underwent PCI for ACS according to aspirin-prasugrel (Effient, Daiichi Sankyo/Eli Lilly) strategy.

News
September 18, 2020
2 min read
Save

Ticagrelor plus aspirin reduces ischemic limb events in diabetes, stable CAD: THEMIS

Ticagrelor plus aspirin reduces ischemic limb events in diabetes, stable CAD: THEMIS

Among patients with diabetes and stable CAD, ticagrelor plus aspirin reduced ischemic limb events compared with aspirin alone, according to new data from the THEMIS randomized controlled trial.

News
September 09, 2020
2 min read
Save

Reducing prasugrel dose 1 month after PCI for ACS improves outcomes

Reducing prasugrel dose 1 month after PCI for ACS improves outcomes

Among patients who underwent PCI for ACS and then had dual antiplatelet therapy with aspirin and prasugrel, halving the prasugrel dose after 1 month conferred reduced risk for net adverse clinical events, researchers reported.

View more